177Lu-FAP-2286 Therapy in a Case of Squamous Lung Cancer

We reported a 72-year-old man who was diagnosed with squamous lung cancer and received 2 cycles of 177 Lu-FAP-2286 treatment. Radiological remission was observed on follow-up FAP imaging 7 months later with squamous cell carcinoma antigen decreased to normal level. No other abnormality monitored by...

Full description

Saved in:
Bibliographic Details
Published in:Clinical nuclear medicine 2025-01, Vol.50 (1), p.103-104
Main Authors: Li, Linwei, Chen, Lingzhi, Zhang, Yanlang, Zhang, Yu, Chen, Yue
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c130t-b153c57386b3c334d7ad9d082ad3ceee3077ec7f6c643463560544505d5ffa193
container_end_page 104
container_issue 1
container_start_page 103
container_title Clinical nuclear medicine
container_volume 50
creator Li, Linwei
Chen, Lingzhi
Zhang, Yanlang
Zhang, Yu
Chen, Yue
description We reported a 72-year-old man who was diagnosed with squamous lung cancer and received 2 cycles of 177 Lu-FAP-2286 treatment. Radiological remission was observed on follow-up FAP imaging 7 months later with squamous cell carcinoma antigen decreased to normal level. No other abnormality monitored by routine laboratory examination was noted.
doi_str_mv 10.1097/RLU.0000000000005489
format article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1097_RLU_0000000000005489</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1097_RLU_0000000000005489</sourcerecordid><originalsourceid>FETCH-LOGICAL-c130t-b153c57386b3c334d7ad9d082ad3ceee3077ec7f6c643463560544505d5ffa193</originalsourceid><addsrcrecordid>eNpdj81KAzEUhYMoOFbfwEVeIPUmNz-TZRmsFgYUbdchzSRasTM1cRZ9e0d0IZ7NgbM4fB8h1xzmHKy5eWo3c_gTJWt7QiquUDMQwp6SClAjs0aLc3JRyhsA11zLitTcmHZky8UjE6LWdP0asz8c6a6nnja-RDok-vwx-v0wFtqO_cu09iHmS3KW_HuJV789I5vl7bq5Z-3D3apZtCxwhE-2nSCCMljrLQZE2Rnf2Q5q4TsMMUYEY2IwSQctUWpUeqKXClSnUvLc4ozIn9-Qh1JyTO6Qd3ufj46D-7Z3k737b49fqUlJgQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>177Lu-FAP-2286 Therapy in a Case of Squamous Lung Cancer</title><source>LWW_医学期刊</source><creator>Li, Linwei ; Chen, Lingzhi ; Zhang, Yanlang ; Zhang, Yu ; Chen, Yue</creator><creatorcontrib>Li, Linwei ; Chen, Lingzhi ; Zhang, Yanlang ; Zhang, Yu ; Chen, Yue</creatorcontrib><description>We reported a 72-year-old man who was diagnosed with squamous lung cancer and received 2 cycles of 177 Lu-FAP-2286 treatment. Radiological remission was observed on follow-up FAP imaging 7 months later with squamous cell carcinoma antigen decreased to normal level. No other abnormality monitored by routine laboratory examination was noted.</description><identifier>ISSN: 0363-9762</identifier><identifier>EISSN: 1536-0229</identifier><identifier>DOI: 10.1097/RLU.0000000000005489</identifier><language>eng</language><ispartof>Clinical nuclear medicine, 2025-01, Vol.50 (1), p.103-104</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c130t-b153c57386b3c334d7ad9d082ad3ceee3077ec7f6c643463560544505d5ffa193</cites><orcidid>0000-0003-4088-7649</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids></links><search><creatorcontrib>Li, Linwei</creatorcontrib><creatorcontrib>Chen, Lingzhi</creatorcontrib><creatorcontrib>Zhang, Yanlang</creatorcontrib><creatorcontrib>Zhang, Yu</creatorcontrib><creatorcontrib>Chen, Yue</creatorcontrib><title>177Lu-FAP-2286 Therapy in a Case of Squamous Lung Cancer</title><title>Clinical nuclear medicine</title><description>We reported a 72-year-old man who was diagnosed with squamous lung cancer and received 2 cycles of 177 Lu-FAP-2286 treatment. Radiological remission was observed on follow-up FAP imaging 7 months later with squamous cell carcinoma antigen decreased to normal level. No other abnormality monitored by routine laboratory examination was noted.</description><issn>0363-9762</issn><issn>1536-0229</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><recordid>eNpdj81KAzEUhYMoOFbfwEVeIPUmNz-TZRmsFgYUbdchzSRasTM1cRZ9e0d0IZ7NgbM4fB8h1xzmHKy5eWo3c_gTJWt7QiquUDMQwp6SClAjs0aLc3JRyhsA11zLitTcmHZky8UjE6LWdP0asz8c6a6nnja-RDok-vwx-v0wFtqO_cu09iHmS3KW_HuJV789I5vl7bq5Z-3D3apZtCxwhE-2nSCCMljrLQZE2Rnf2Q5q4TsMMUYEY2IwSQctUWpUeqKXClSnUvLc4ozIn9-Qh1JyTO6Qd3ufj46D-7Z3k737b49fqUlJgQ</recordid><startdate>202501</startdate><enddate>202501</enddate><creator>Li, Linwei</creator><creator>Chen, Lingzhi</creator><creator>Zhang, Yanlang</creator><creator>Zhang, Yu</creator><creator>Chen, Yue</creator><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0003-4088-7649</orcidid></search><sort><creationdate>202501</creationdate><title>177Lu-FAP-2286 Therapy in a Case of Squamous Lung Cancer</title><author>Li, Linwei ; Chen, Lingzhi ; Zhang, Yanlang ; Zhang, Yu ; Chen, Yue</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c130t-b153c57386b3c334d7ad9d082ad3ceee3077ec7f6c643463560544505d5ffa193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Linwei</creatorcontrib><creatorcontrib>Chen, Lingzhi</creatorcontrib><creatorcontrib>Zhang, Yanlang</creatorcontrib><creatorcontrib>Zhang, Yu</creatorcontrib><creatorcontrib>Chen, Yue</creatorcontrib><collection>CrossRef</collection><jtitle>Clinical nuclear medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Linwei</au><au>Chen, Lingzhi</au><au>Zhang, Yanlang</au><au>Zhang, Yu</au><au>Chen, Yue</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>177Lu-FAP-2286 Therapy in a Case of Squamous Lung Cancer</atitle><jtitle>Clinical nuclear medicine</jtitle><date>2025-01</date><risdate>2025</risdate><volume>50</volume><issue>1</issue><spage>103</spage><epage>104</epage><pages>103-104</pages><issn>0363-9762</issn><eissn>1536-0229</eissn><abstract>We reported a 72-year-old man who was diagnosed with squamous lung cancer and received 2 cycles of 177 Lu-FAP-2286 treatment. Radiological remission was observed on follow-up FAP imaging 7 months later with squamous cell carcinoma antigen decreased to normal level. No other abnormality monitored by routine laboratory examination was noted.</abstract><doi>10.1097/RLU.0000000000005489</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0003-4088-7649</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0363-9762
ispartof Clinical nuclear medicine, 2025-01, Vol.50 (1), p.103-104
issn 0363-9762
1536-0229
language eng
recordid cdi_crossref_primary_10_1097_RLU_0000000000005489
source LWW_医学期刊
title 177Lu-FAP-2286 Therapy in a Case of Squamous Lung Cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T12%3A53%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=177Lu-FAP-2286%20Therapy%20in%20a%20Case%20of%20Squamous%20Lung%20Cancer&rft.jtitle=Clinical%20nuclear%20medicine&rft.au=Li,%20Linwei&rft.date=2025-01&rft.volume=50&rft.issue=1&rft.spage=103&rft.epage=104&rft.pages=103-104&rft.issn=0363-9762&rft.eissn=1536-0229&rft_id=info:doi/10.1097/RLU.0000000000005489&rft_dat=%3Ccrossref%3E10_1097_RLU_0000000000005489%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c130t-b153c57386b3c334d7ad9d082ad3ceee3077ec7f6c643463560544505d5ffa193%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true